Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,473,226
+$57,351 QoQ
Shares Held
27,029
-4.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1,251
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUE Private Wealth Advisors holds $27,309,850 across 8 Drug Manufacturers - General names. MRK ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,739 | $8,082,959 | |
| 2 | JNJ |
Johnson & Johnson
|
26,804 | $6,807,411 | |
| 3 | ABBV |
AbbVie Inc.
|
24,787 | $6,237,400 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
27,029 | $3,473,226 | |
| 5 | PFE |
Pfizer Inc
|
66,968 | $1,612,589 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,727 | $560,469 | |
| 7 | AMGN |
Amgen Inc
|
808 | $292,592 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,925 | $243,204 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,473,226 | 27,029 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,415,875 | 28,397 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $757,240 | 7,194 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $622,508 | 7,417 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $550,557 | 6,955 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $556,242 | 6,197 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $547,239 | 5,501 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $630,258 | 5,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $697,860 | 5,637 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $746,309 | 5,656 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $604,406 | 5,544 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $593,918 | 5,769 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $650,338 | 5,636 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $679,406 | 6,386 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $725,280 | 6,537 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $654,770 | 7,603 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $670,464 | 7,354 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $653,200 | 7,961 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $667,074 | 8,704 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $596,673 | 7,944 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $687,797 | 8,844 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $848,684 | 11,009 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $859,554 | 10,508 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $979,557 | 11,809 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $984,488 | 12,731 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $948,131 | 12,323 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||